VRT.CN - Veritas Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 51.7M
Enterprise Value 31.67M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.72

Trading Information

Stock Price History

Beta (5Y Monthly) 0.55
52-Week Change 3-89.17%
S&P500 52-Week Change 325.98%
52 Week High 31.3000
52 Week Low 30.0000
50-Day Moving Average 30.1584
200-Day Moving Average 30.2432

Share Statistics

Avg Vol (3 month) 36.83k
Avg Vol (10 day) 34.63k
Shares Outstanding 512.16M
Float 11.27M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Dec. 12, 2019) 49.69k
Short Ratio (Dec. 12, 2019) 448.88
Short % of Float (Dec. 12, 2019) 4N/A
Short % of Shares Outstanding (Dec. 12, 2019) 40.08%
Shares Short (prior month Oct. 14, 2019) 435

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Feb. 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Apr. 29, 2019
Most Recent Quarter (mrq)Oct. 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-50.30%
Return on Equity (ttm)-555.13%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -2.33M
Net Income Avi to Common (ttm)-11.1M
Diluted EPS (ttm)-0.9590
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)32.52k
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.07
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-617.35k
Levered Free Cash Flow (ttm)1.76M